Data are "conflicting and too limited to make a definitive conclusion," FDA says after reviewing scientific data concerning effectiveness of Plan B One Step and other 1.5mg levonorgestrel emergency contraceptives in women weighing more than 165 pounds.

Data are "conflicting and too limited to make a definitive conclusion" FDA says after reviewing scientific data concerning effectiveness of Plan B One Step and other 1.5mg levonorgestrel emergency contraceptives in women weighing more than 165 pounds.

Data are "conflicting and too limited to make a definitive conclusion" FDA says after reviewing scientific data concerning effectiveness of Plan B One Step and other 1.5mg levonorgestrel emergency contraceptives in women weighing more than 165 pounds.

A record-breaking private financing for a Chinese biotech has seen bets placed on Suzhou-based Innovent Bio, which has 10 monoclonal antibodies including four biosimilars in its pipeline.